🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to investigate possible effects of radio frequ...
Status
Completed
Location
Competence Center Sleep Medicine
Start Date
2014-04-01
Trial ID
NCT02906228
The purpose of this study is to evaluate pulmonary capillary wedge pressure...
Status
Recruiting
Location
Mayo Clinic in Rochester
Start Date
2026-01-22
Trial ID
NCT06220396
Radiotherapy (RT) is an important option for patients with limited stage FL...
Status
Unknown
Location
DiDeng
Start Date
2015-10
Trial ID
NCT02449252
To determine the safety and efficacy of Gliadel 3.85% wafers plus surgery a...
Status
Unknown
Location
Kentuckiana Cancer Institute
Start Date
2002-09
Trial ID
NCT00283543
Treatments Being Tested
The most common option of radiotherapy for patients with limited-stage DLBC...
Status
Unknown
Location
DiDeng
Start Date
2015-10
Trial ID
NCT02449265
Globally, tuberculosis (TB) is one of the main causes of death and the lead...
Status
Completed
Location
Icddr,B
Start Date
2025-02-28
Trial ID
NCT05845112
Treatments Being Tested
RATIONALE: Giving intensity modulated radiation therapy (IMRT) and chemothe...
Status
Completed
Location
City of Hope Medical Center
Start Date
2008-03-04
Trial ID
NCT00576979
Combined modality therapy has then emerged as the standard of care for limi...
Status
Terminated
Location
UT MD Anderson Cancer Center
Start Date
2009-09
Trial ID
NCT00992030
Treatments Being Tested
RATIONALE: Quality of life assessment in patients undergoing prostate cance...
Status
Completed
Location
Sir Charles Gairdner Hospital - Perth
Start Date
2002-03
Trial ID
NCT00041301
Treatments Being Tested
To determine the safety and efficacy of surgical resection with Gliadel® 3....
Status
Unknown
Location
Kentuckiana Cancer Institute
Start Date
2008-04
Trial ID
NCT00660621
Treatments Being Tested